Literature DB >> 25577322

An exploratory qualitative assessment of self-reported treatment outcomes and satisfaction among patients accessing an innovative voluntary drug treatment centre in Malaysia.

Mansur A Ghani1, Shan-Estelle Brown1, Farrah Khan1, Jeffrey A Wickersham1, Sin How Lim2, Sangeeth K Dhaliwal3, Adeeba Kamarulzaman4, Frederick L Altice5.   

Abstract

BACKGROUND: In Malaysia, compulsory drug detention centres (CDDCs) hold suspected drug users for two years without adjudication. Acute detoxification without healthcare access has been documented. CDDCs are criticized globally due to ineffectiveness in treating addiction and human rights violations. In response, the Malaysian government began transitioning these facilities into voluntary drug treatment centres known as "Cure and Care" (C&C) centres that embrace a holistic treatment-based approach to drug addiction rehabilitation.
METHODS: An explorative qualitative study was undertaken to explore patient perspectives and satisfaction regarding treatment and services at the new Cure and Care centre in Kota Bharu, Malaysia. A convenience sample of 20 patients was recruited to participate in semi-structured in-depth interviews. Content analysis was used to identify the salient themes.
RESULTS: Patients identified methadone treatment, psychosocial programs, religious instruction, and recreational activities as important factors contributing to treatment success for addressing both health and addiction needs. Though many had previously been in a CDDC, adherence to treatment in the C&C centre was perceived to be facilitated by the degree of social support, the voluntary nature and the array of new programs available for selection.
CONCLUSION: C&Cs represents a dramatic shift in the Malaysian government's approach to drug addiction. Our findings demonstrate positive patient experiences associated with the holistic treatment-based approach of these centres. This exploratory study provides additional evidence to document this ongoing policy transition and may guide continued expansion of new holistic drug treatment programs across the country.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Compulsory drug detention centres; Malaysia; Patient satisfaction; Qualitative research; Voluntary addiction treatment

Mesh:

Year:  2014        PMID: 25577322      PMCID: PMC4291539          DOI: 10.1016/j.drugpo.2014.10.002

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  45 in total

1.  Modified therapeutic community for homeless mentally ill chemical abusers: treatment outcomes.

Authors:  G De Leon; S Sacks; G Staines; K McKendrick
Journal:  Am J Drug Alcohol Abuse       Date:  2000-08       Impact factor: 3.829

2.  Development of a bibliography on religion, spirituality and addictions.

Authors:  Cynthia Geppert; Michael P Bogenschutz; William R Miller
Journal:  Drug Alcohol Rev       Date:  2007-07

Review 3.  Translation and back-translation in qualitative nursing research: methodological review.

Authors:  Hsiao-Yu Chen; Jennifer Rp Boore
Journal:  J Clin Nurs       Date:  2009-11-03       Impact factor: 3.036

4.  Patient preferences and randomised clinical trials.

Authors:  C R Brewin; C Bradley
Journal:  BMJ       Date:  1989-07-29

5.  Assessing the effectiveness of Malaysia's drug prevention education and rehabilitation programs.

Authors:  J F Scorzelli
Journal:  J Subst Abuse Treat       Date:  1988

Review 6.  Therapeutic communities for addictions: a theoretical framework.

Authors:  G De Leon
Journal:  Int J Addict       Date:  1995

7.  Patient preferences in randomised trials: threat or opportunity?

Authors:  D J Torgerson; J Klaber-Moffett; I T Russell
Journal:  J Health Serv Res Policy       Date:  1996-10

8.  Are randomized controlled trials controlled? Patient preferences and unblind trials.

Authors:  K McPherson; A R Britton; J E Wennberg
Journal:  J R Soc Med       Date:  1997-12       Impact factor: 5.344

9.  How we design feasibility studies.

Authors:  Deborah J Bowen; Matthew Kreuter; Bonnie Spring; Ludmila Cofta-Woerpel; Laura Linnan; Diane Weiner; Suzanne Bakken; Cecilia Patrick Kaplan; Linda Squiers; Cecilia Fabrizio; Maria Fernandez
Journal:  Am J Prev Med       Date:  2009-05       Impact factor: 5.043

10.  Exploring intentions to discriminate against patients living with HIV/AIDS among future healthcare providers in Malaysia.

Authors:  Valerie A Earnshaw; Harry Jin; Jeffrey Wickersham; Adeeba Kamarulzaman; Jacob John; Frederick L Altice
Journal:  Trop Med Int Health       Date:  2014-03-26       Impact factor: 2.622

View more
  14 in total

1.  HIV Prevalence Among People Who Inject Drugs in Greater Kuala Lumpur Recruited Using Respondent-Driven Sampling.

Authors:  Alexander R Bazazi; Forrest Crawford; Alexei Zelenev; Robert Heimer; Adeeba Kamarulzaman; Frederick L Altice
Journal:  AIDS Behav       Date:  2015-12

2.  Assessment of an Innovative Voluntary Substance Abuse Treatment Program Designed to Replace Compulsory Drug Detention Centers in Malaysia.

Authors:  Farrah Khan; Archana Krishnan; Mansur A Ghani; Jeffrey A Wickersham; Jeannia J Fu; Sin How Lim; Sangeeth Kaur Dhaliwal; Adeeba Kamarulzaman; Frederick L Altice
Journal:  Subst Use Misuse       Date:  2017-02-22       Impact factor: 2.164

3.  Pretreatment drug use characteristics and experiences among patients in a voluntary substance abuse treatment center in Malaysia: A mixed-methods approach.

Authors:  Archana Krishnan; Shan-Estelle Brown; Mansur A Ghani; Farrah Khan; Adeeba Kamarulzaman; Frederick L Altice
Journal:  Subst Abus       Date:  2016-02-25       Impact factor: 3.716

4.  Treatment readiness, attitudes toward, and experiences with methadone and buprenorphine maintenance therapy among people who inject drugs in Malaysia.

Authors:  Aishwarya Vijay; Alexander R Bazazi; Ilias Yee; Adeeba Kamarulzaman; Frederick L Altice
Journal:  J Subst Abuse Treat       Date:  2015-02-18

5.  The relationship between health policy and public health interventions: a case study of the DRIVE project to "end" the HIV epidemic among people who inject drugs in Haiphong, Vietnam.

Authors:  Theodore M Hammett; Nguyen Thu Trang; Khuat Thi Hai Oanh; Nguyen Thi Huong; Le Minh Giang; Duong Thi Huong; Nicolas Nagot; Don C Des Jarlais
Journal:  J Public Health Policy       Date:  2018-05       Impact factor: 2.222

6.  A systematic review of patients' and providers' perspectives of medications for treatment of opioid use disorder.

Authors:  Katharine Cioe; Breanne E Biondi; Rebecca Easly; Amanda Simard; Xiao Zheng; Sandra A Springer
Journal:  J Subst Abuse Treat       Date:  2020-09-22

7.  High prevalence of non-fatal overdose among people who inject drugs in Malaysia: Correlates of overdose and implications for overdose prevention from a cross-sectional study.

Authors:  Alexander R Bazazi; Alexei Zelenev; Jeannia J Fu; Ilias Yee; Adeeba Kamarulzaman; Frederick L Altice
Journal:  Int J Drug Policy       Date:  2014-12-02

8.  Relapse to opioid use in opioid-dependent individuals released from compulsory drug detention centres compared with those from voluntary methadone treatment centres in Malaysia: a two-arm, prospective observational study.

Authors:  Martin P Wegman; Frederick L Altice; Sangeeth Kaur; Vanesa Rajandaran; Sutayut Osornprasop; David Wilson; David P Wilson; Adeeba Kamarulzaman
Journal:  Lancet Glob Health       Date:  2016-12-08       Impact factor: 26.763

9.  Patterns of substance use and correlates of lifetime and active injection drug use among women in Malaysia.

Authors:  Jeffrey A Wickersham; Kelsey B Loeliger; Ruthanne Marcus; Veena Pillai; Adeeba Kamarulzaman; Frederick L Altice
Journal:  Am J Drug Alcohol Abuse       Date:  2015-12-04       Impact factor: 3.829

Review 10.  Confronting the HIV, Tuberculosis, Addiction, and Incarceration Syndemic in Southeast Asia: Lessons Learned from Malaysia.

Authors:  Gabriel J Culbert; Veena Pillai; Joseph Bick; Haider A Al-Darraji; Jeffrey A Wickersham; Martin P Wegman; Alexander R Bazazi; Enrico Ferro; Michael Copenhaver; Adeeba Kamarulzaman; Frederick L Altice
Journal:  J Neuroimmune Pharmacol       Date:  2016-05-24       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.